M. Kuzu Et Al. , "An experience of changing from onabotulinumtoxin a to abobotulinumtoxin a in 64 patients with focal hyperkinesias," 19th International Congress of Parkinson's Disease and Movement Disorders , 2015
Kuzu, M. Et Al. 2015. An experience of changing from onabotulinumtoxin a to abobotulinumtoxin a in 64 patients with focal hyperkinesias. 19th International Congress of Parkinson's Disease and Movement Disorders .
Kuzu, M., Gül, Ş., Tezcan, S., & AKBOSTANCI, M. C., (2015). An experience of changing from onabotulinumtoxin a to abobotulinumtoxin a in 64 patients with focal hyperkinesias . 19th International Congress of Parkinson's Disease and Movement Disorders
Kuzu, M Et Al. "An experience of changing from onabotulinumtoxin a to abobotulinumtoxin a in 64 patients with focal hyperkinesias," 19th International Congress of Parkinson's Disease and Movement Disorders, 2015
Kuzu, M Et Al. "An experience of changing from onabotulinumtoxin a to abobotulinumtoxin a in 64 patients with focal hyperkinesias." 19th International Congress of Parkinson's Disease and Movement Disorders , 2015
Kuzu, M. Et Al. (2015) . "An experience of changing from onabotulinumtoxin a to abobotulinumtoxin a in 64 patients with focal hyperkinesias." 19th International Congress of Parkinson's Disease and Movement Disorders .
@conferencepaper{conferencepaper, author={M Kuzu Et Al. }, title={An experience of changing from onabotulinumtoxin a to abobotulinumtoxin a in 64 patients with focal hyperkinesias}, congress name={19th International Congress of Parkinson's Disease and Movement Disorders}, city={}, country={}, year={2015}}